InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Kim Austin d.. Director active across 1 company, notably Acadia Pharmaceuticals INC. Cumulatively, 11 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €43k. History available since 23 February 2022. The latest transaction was disclosed on 8 January 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kim Austin d.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
1,634 sharesCommon StockSEC:0001209191-24-001267:0
590 shares@ US$29.9637.3% of flowCommon StockSEC:0001209191-24-001267:1
36,174 sharesCommon StockSEC:0001209191-23-052390:0
917 shares@ US$21.1840.9% of flowCommon StockSEC:0001209191-23-026746:1
3,005 sharesCommon StockSEC:0001209191-23-026746:0
4,773 sharesCommon StockSEC:0001209191-23-023861:0
1,633 sharesCommon StockSEC:0001209191-23-002894:0
589 shares@ US$17.130321.9% of flowCommon StockSEC:0001209191-23-002894:1
3,005 sharesCommon StockSEC:0001209191-22-026938:0
2,213 shares0Common StockSEC:0001209191-22-013277:0
1,633 sharesCommon StockSEC:0001209191-22-002750:0
11 of 11 declarations
About Kim Austin d.
KIM AUSTIN D. is a declarant linked to Acadia Pharmaceuticals INC, where the listed role is EVP, General Counsel, Secretary. There are 11 filings in total, and across the 11 sampled filings between 2022-01-10 and 2024-01-09, sales total 43329 EUR and the most frequent transaction nature is Levée d'options.
